Drug intelligence / Profile preview

Daylong Actinica

Development stage
Unknown
Lead developer
Galderma
Modality
Small Molecules
Administration
Topical
01

Overview

**Daylong Actinica** is a broad-spectrum sunscreen lotion (SPF 50+) specifically formulated for patients at high risk of non-melanoma skin cancer, including those with actinic keratosis, a history of skin cancer, photodamaged skin from chronic UV exposure, or immunosuppression (e.g., organ transplant recipients, autoimmune diseases). It features a unique combination of photostable chemical and hybrid UV filters—**Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (Tinosorb S)**, **Ethylhexyl Triazone**, **Isoamyl p-Methoxycinnamate**, **Ethylhexyl Methoxycinnamate (Octinoxate)**, **Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (Tinosorb M)**, and **Butyl Methoxydibenzoylmethane (Avobenzone)**—providing comprehensive UVA/UVB protection (280-400 nm). Clinical studies demonstrate its efficacy in reducing actinic keratosis lesions and preventing squamous cell carcinoma in at-risk populations. The lightweight, non-greasy, fragrance-free, water-resistant (4 hours) formula with liposomal delivery enhances daily compliance and skin hydration, dispensed via an airless pump for precise dosing (0.5g per application).[1][2][3][5][9][10][11]

Brand names
Daylong ActinicaActinica Lotion
Other names
Galderma Actinica Lotion SPF 50+

Beyond the preview

Go deeper on Daylong Actinica.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daylong Actinica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call